The price of HPMC is bullish in June

In the first half of 2015, the overall performance of China's market economy was generally low, and the price of HPMC also reached the bottom line of cost price.

On May 18, the website of the national development and Reform Commission issued an official reply to more than 450 billion yuan of infrastructure projects. In the following time, a large number of steady growth projects will be released one after another, and the investment in network construction will also exceed 400 billion yuan this year. At the same time, under the pressure of environmental construction, many local PPP projects are speeding up, and many projects will be implemented in the near future. In June, with the implementation of these projects, it stimulated the vitality of the whole building materials market and brought huge profits to the whole building materials market. As an important additive in the building materials industry, hydroxypropyl methylcellulose also rose. The price of hydroxypropyl methylcellulose will meet the first wave of rise in 2015.


羟丙基甲基纤维素


Many people in the industry believe that in the face of the pressure of steady growth of the macro economy, speeding up investment in infrastructure projects is an important starting point to ensure steady economic growth. A number of financial measures have been taken by relevant departments to support infrastructure investment, and financial support has been strengthened. Our building materials industry should pay attention to the positive trend of infrastructure investment and improve the overall operation efficiency. At present, the national development and Reform Commission approved the construction plan of rail transit in Nanjing, Nanchang and Hohhot on May 20, involving a total investment of 215.191 billion yuan. Taking these hydroxypropyl methylcellulose as a whole, to meet the market demand and adjust the relationship between supply and demand, the price is bound to rise.


{aspcms:comment}
About us | Contact us | Product | News
Copyright (c) 2015-2021 Shandong chuangyao Biotechnology Co., Ltd